alexa Joseph Spernyak
ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Joseph Spernyak

Roswell Park Cancer Institute, USA.

He works as a Professor in Department of Cancer Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

Research Interest

Colon cancer, Chemotherapy and Anti-Cancer Drugs.


Anti-tumor Activity of IGF-1R Kinase Inhibitor PQIP in Colon Cancer

Sanjib Chowdhury, Ivan Dominguez, Elizabeth Sharratt, Joseph Spernyak, Michael G Brattain and Ashwani Rajput

Research Article: Clinic Experiment Pharmacol 2013, S4:005

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version